111 (YI) Net Income towards Common Stockholders (2017 - 2025)
111's (YI) quarterly Net Income towards Common Stockholders came in at -$2.3 million in Q4 2025, up 14.64% year-on-year from -$2.0 million in Q4 2024, and down 27.4% quarter-over-quarter from -$1.8 million in Q3 2025.
111 (YI) Net Income towards Common Stockholders (2017 - 2025) Analysis & Trends
111 has disclosed Net Income towards Common Stockholders across 9 years of filings, most recently posting -$2.3 million for Q4 2025.
- Net Income towards Common Stockholders for Q4 2025 came in at -$2.3 million, up 14.64% year-over-year; the trailing twelve-month figure through Dec 2025 was -$9.3 million (down 3.42% YoY), and the FY2025 annual result was -$9.5 million, down 7.03% from the prior year.
- Net Income towards Common Stockholders came in at -$2.3 million for Q4 2025 at 111, down from -$1.8 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$1.8 million in Q3 2025 to a low of -$39.1 million in Q3 2021.
- The 5-year median for Net Income towards Common Stockholders is -$10.3 million (2023), against an average of -$11.9 million.
- Across the five-year window, Net Income towards Common Stockholders tumbled 144.46% in 2021 and jumped 90.83% in 2024, its largest moves.
- 111's Net Income towards Common Stockholders stood at -$17.5 million in 2021, then gained by 5.05% to -$16.6 million in 2022, then slumped by 78.6% to -$29.6 million in 2023, then surged by 90.83% to -$2.7 million in 2024, then increased by 14.64% to -$2.3 million in 2025.
- The last three Net Income towards Common Stockholders figures came in at -$2.3 million (Q4 2025), -$1.8 million (Q3 2025), and -$2.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 1.86 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 380.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -541.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -9.08 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -2.32 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -2.81 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.32 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -2.73 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Dec 31, 2024 | -2.72 Mn |
| Sep 30, 2024 | -2.44 Mn |
| Jun 30, 2024 | -1.93 Mn |
| Mar 31, 2024 | -1.91 Mn |
| Dec 31, 2023 | -29.63 Mn |
| Sep 30, 2023 | -12.79 Mn |
| Jun 30, 2023 | -7.89 Mn |
| Mar 31, 2023 | -4.63 Mn |
| Dec 31, 2022 | -16.59 Mn |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | -14.22 Mn |
| Mar 31, 2022 | -17.41 Mn |
| Dec 31, 2021 | -17.47 Mn |
| Sep 30, 2021 | -39.09 Mn |
| Jun 30, 2021 | -24.62 Mn |
| Mar 31, 2021 | -22.38 Mn |